Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-04-24 00:00:00 ET · period of report 2024-04-22 · accession 0001140361-24-021817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-24 | 2024-04-22 | ROIV | Pulik Richard | CFO | A - Grant | $0.00 | +38.7K | 297.4K | +15% | $0 |
| D | 2024-04-24 | 2024-04-22 | ROIV | Pulik Richard | CFO | A - Grant | $0.00 | +302.6K | 302.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-04-22 | A | A | 38,685 | $0.00 | 297,382 | D | — | — | (F1) Reflects an award of 38,685 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2024. 1/4 of the RSUs service-vest on the date thirteen (13) months from the vesting commencement date; and the balance of the RSUs service-vest in series of twelve (12) successive equal quarterly installments measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-04-22 | A | A | 302,594 | $0.00 | 302,594 | D | $10.60 · — to 2034-04-21 | 302,594 Common Shares | (F2) Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date. |